K. AYDIN And E. Gurkan, "Efficacy of high-dose methylprednisolone as a first-line therapy in adult patients with immune thrombocytopenia," CUKUROVA MEDICAL JOURNAL , vol.47, no.2, pp.715-721, 2022
AYDIN, K. And Gurkan, E. 2022. Efficacy of high-dose methylprednisolone as a first-line therapy in adult patients with immune thrombocytopenia. CUKUROVA MEDICAL JOURNAL , vol.47, no.2 , 715-721.
AYDIN, K., & Gurkan, E., (2022). Efficacy of high-dose methylprednisolone as a first-line therapy in adult patients with immune thrombocytopenia. CUKUROVA MEDICAL JOURNAL , vol.47, no.2, 715-721.
AYDIN, KANİYE, And Emel Gurkan. "Efficacy of high-dose methylprednisolone as a first-line therapy in adult patients with immune thrombocytopenia," CUKUROVA MEDICAL JOURNAL , vol.47, no.2, 715-721, 2022
AYDIN, KANİYE And Gurkan, Emel. "Efficacy of high-dose methylprednisolone as a first-line therapy in adult patients with immune thrombocytopenia." CUKUROVA MEDICAL JOURNAL , vol.47, no.2, pp.715-721, 2022
AYDIN, K. And Gurkan, E. (2022) . "Efficacy of high-dose methylprednisolone as a first-line therapy in adult patients with immune thrombocytopenia." CUKUROVA MEDICAL JOURNAL , vol.47, no.2, pp.715-721.
@article{article, author={KANİYE AYDIN And author={Emel Gurkan}, title={Efficacy of high-dose methylprednisolone as a first-line therapy in adult patients with immune thrombocytopenia}, journal={CUKUROVA MEDICAL JOURNAL}, year=2022, pages={715-721} }